Z. Lou, X. Wang, C. Hu, W. Liu, and Y. Ji, “Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer”, Pak J Med Sci, vol. 40, no. 7, Jun. 2024.